000 01407 a2200397 4500
005 20250513191018.0
264 0 _c19991029
008 199910s 0 0 eng d
022 _a0891-9887
024 7 _a10.1177/089198879901200107
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTrabucchi, M
245 0 0 _aAn economic perspective on Alzheimer's disease.
_h[electronic resource]
260 _bJournal of geriatric psychiatry and neurology
_c1999
300 _a29-38 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aActivities of Daily Living
650 0 4 _aAlzheimer Disease
_xeconomics
650 0 4 _aCholinesterase Inhibitors
_xtherapeutic use
650 0 4 _aCognition Disorders
_xdiagnosis
650 0 4 _aCombined Modality Therapy
650 0 4 _aCost of Illness
650 0 4 _aCosts and Cost Analysis
650 0 4 _aDonepezil
650 0 4 _aHumans
650 0 4 _aIndans
_xtherapeutic use
650 0 4 _aInstitutionalization
_xeconomics
650 0 4 _aItaly
650 0 4 _aMental Health Services
_xeconomics
650 0 4 _aNeuropsychological Tests
650 0 4 _aPiperidines
_xtherapeutic use
650 0 4 _aReality Therapy
650 0 4 _aTacrine
_xtherapeutic use
773 0 _tJournal of geriatric psychiatry and neurology
_gvol. 12
_gno. 1
_gp. 29-38
856 4 0 _uhttps://doi.org/10.1177/089198879901200107
_zAvailable from publisher's website
999 _c10404876
_d10404876